Empfehlung
8,5
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | NATURES SUNSHINE PRODUCTS INC |
|---|---|
| Ticker | NATR |
| CIK | 0000275053 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | NATURES SUNSHINE PRODUCTS INC |
Status
| Zuletzt geprüft | 2026-03-20 21:32:43.503442 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | Lanoy Jonathan David | Officer, SVP, Chief Accounting Officer | Open Market Sale | -4,000 | 24.70 | -98,800.00 | -6,3% | |
| 2026-03-13 | Norman Daniel C | Officer, EVP & President, Asia | Open Market Sale | -15,383 | 24.52 | -377,191.16 | -23,9% | |
| 2026-03-13 | Norman Daniel C | Officer, EVP & President, Asia | Open Market Sale | -15,383 | 24.52 | -377,191.16 | -23,9% | |
| 2026-03-13 | Yates Bryant J | Officer, EVP & President, Europe | Open Market Sale | -19,516 | 24.35 | -475,214.60 | -30,2% | |
| 2026-03-13 | Yates Bryant J | Officer, EVP & President, Europe | Open Market Sale | -19,516 | 24.35 | -475,214.60 | -30,2% | |
| 2026-03-13 | Lanoy Jonathan David | Officer, SVP, Chief Accounting Officer | Open Market Sale | -4,000 | 24.70 | -98,800.00 | -6,3% | |
| 2025-12-12 | Yates Bryant J | Officer, EVP & President, Europe | Open Market Sale | -1,700 | 22.29 | -37,893.00 | -2,4% | |
| 2025-12-12 | Yates Bryant J | Officer, EVP & President, Europe | Open Market Sale | -1,700 | 22.29 | -37,893.00 | -2,4% | |
| 2025-11-18 | Lanoy Jonathan David | Officer, SVP, Chief Accounting Officer | Open Market Sale | -5,000 | 20.45 | -102,250.00 | -6,5% | |
| 2025-11-18 | Lanoy Jonathan David | Officer, SVP, Chief Accounting Officer | Open Market Sale | -5,000 | 20.45 | -102,250.00 | -6,5% | |
| 2025-11-14 | Brower Nathan G | Officer, EVP, General Counsel | Open Market Sale | -3,800 | 20.81 | -79,078.00 | -5,0% | |
| 2025-11-14 | Brower Nathan G | Officer, EVP, General Counsel | Open Market Sale | -3,800 | 20.81 | -79,078.00 | -5,0% | |
| 2025-11-12 | Norman Daniel C | Officer, EVP & President, Asia | Open Market Sale | -8,884 | 20.46 | -181,766.64 | -11,5% | |
| 2025-11-12 | Norman Daniel C | Officer, EVP & President, Asia | Open Market Sale | -8,884 | 20.46 | -181,766.64 | -11,5% | |
| 2025-08-29 | Yates Bryant J | Officer, EVP & President, Europe | Open Market Sale | -4,672 | 16.71 | -78,069.12 | -5,0% | |
| 2025-08-29 | Yates Bryant J | Officer, EVP & President, Europe | Open Market Sale | -4,672 | 16.71 | -78,069.12 | -5,0% | |
| 2025-08-26 | Yates Bryant J | Officer, EVP & President, Europe | Open Market Sale | -5,000 | 16.77 | -83,850.00 | -5,3% | |
| 2025-08-26 | Yates Bryant J | Officer, EVP & President, Europe | Open Market Sale | -5,000 | 16.77 | -83,850.00 | -5,3% | |
| 2025-08-13 | Brower Nathan G | Officer, EVP, General Counsel | Open Market Sale | -9,996 | 16.54 | -165,333.84 | -10,5% | |
| 2025-08-13 | Lanoy Jonathan David | Officer, SVP, Chief Accounting Officer | Open Market Sale | -5,000 | 16.51 | -82,550.00 | -5,2% | |
| 2025-08-13 | Lanoy Jonathan David | Officer, SVP, Chief Accounting Officer | Open Market Sale | -5,000 | 16.51 | -82,550.00 | -5,2% | |
| 2025-08-13 | Brower Nathan G | Officer, EVP, General Counsel | Open Market Sale | -9,996 | 16.54 | -165,333.84 | -10,5% | |
| 2025-06-27 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | Open Market Sale | -2,854,607 | 11.46 | -32,713,796.22 | -2076,3% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.